Mumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Pithampur ...

Lupin's Pithampur manufacturing unit produces both APIs (Active Pharmaceutical Ingredients) and finished products ...

Global pharma major Lupin Limited (Lupin) announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (FDA) for its Pithampur Unit-1 ...

Lupin, a global pharmaceutical company, announced that it has received a Voluntary Action Indicated (VAI) classification from the United States Food and Drug Administration (US FDA) for its Pithampur ...

Pharma company Lupin Ltd announced on Wednesday that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its Pithampur Unit-1 ...

The Food and Drug Administration has given Lupin a tentative nod for two new generics. The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s ...

Lupin is an innovation led Transnational Pharmaceutical Company producing developing and ... Lupin Receives EIR from U. S. FDA for its Pithampur Unit-1 Facility with VAI Classification. Certificate ...

Pharma sector grew 8% in FY24: Report The product will be manufactured at Lupin’s Pithampur facility in India. Prednisolone Acetate Ophthalmic Suspension USP, 1% is indicated for the treatment ...

of Janssen Pharmaceuticals, Inc. This product will be manufactured at Lupin’s Pithampur facility in India. USFDA gives nod to Lupin’s generic formulation to treat high uric acid Rivaroxaban ...